TY PHAR. announced that its drug Doxycycline Hydrochloride Tablets have passed the consistency evaluation, with two specifications of 0.05g and 0.1g. Doxycycline Hydrochloride Tablets are mainly used for upper respiratory tract infections, tonsillitis, biliary tract infections, lymphadenitis, cellulitis, chronic bronchitis in the elderly, and other conditions caused by sensitive Gram-positive cocci and Gram-negative bacilli. They are also used for typhus, scrub typhus, and mycoplasma pneumonia. Passing the consistency evaluation is beneficial for the company to participate in centralized procurement bidding, enhance the market competitiveness of its products, and expand its market share
